Since IL-17 was first discovered as an inflammatory cytokine that affects autoimmune diseases such as psoriasis, here, we summarize the signaling mechanism of IL-17 in the pathogenesis of pancreatic cancer, which may provide new opportunities for therapeutic intervention. This evidence concerns the gene IL17A and autoimmune disease.